Omnicell Inc (NASDAQ:OMCL) Sentiment Increased to 1.1, Despite

Omnicell, Inc. (NASDAQ:OMCL) Corporate Logo

Omnicell Inc’s Sentiment

In 2018 Q2 Omnicell Inc (NASDAQ:OMCL) big money sentiment increased to 1.1, according to SEC filings. So its up 0.07, from 2018Q1’s 1.03. 92 funds increased or opened new equity positions, while 84 trimmed and sold stock positions in Omnicell Inc so the sentiment is positive. These funds own 39.79 million shares, that’s up from 37.13 million shares in 2018Q1. Funds holding Omnicell Inc in top 10 increased from 2 to 5 for an increase of 3. In total 15 funds closed positions, 69 reduced and 63 increased. Also 29 funds bought new Omnicell Inc stakes.

Significant Omnicell Inc Investors

First Light Asset Management Llc owns 666,109 shares in Omnicell Inc as of 2018 Q2. As of 2018 Q2, 1.83 million shares of Omnicell Inc are owned by Conestoga Capital Advisors Llc. Kopp Investment Advisors Llc reported 67,320 shares. Falcon Point Capital Llc revealed 224,825 shares position in Omnicell Inc. The Minnesota-based fund Summit Creek Advisors Llc holds 239,029 shares or 2.25% of their portfolio.

Omnicell, Inc. provides automation and business analytics software solutions for medication and supply management in healthcare worldwide.The company has $2.81 billion market cap. The firm operates through two divisions, Automation and Analytics, and Medication Adherence.65.7 is the P/E ratio. It offers Omnicell Automated Dispensing Cabinets, a dispensing system, which automates the management and dispensing of medications; SinglePointe, a software product that controls medications; AnywhereRN, which remotely queue medications from automated dispensing cabinets; Omnicell Analytics and Pandora Analytics reporting and data analytics tools; and Savvy Mobile Medication Workstation, which provides a platform for hospital information systems.

OMCL reached $70.96 during the last trading session after $3.76 change.Omnicell, Inc. is uptrending after having risen 34.45% since December 6, 2017. OMCL has 525,865 volume or 39.33% up from normal. OMCL outperformed the S&P500 by 18.83%.

On February, 7 Omnicell, Inc. (NASDAQ:OMCL)’s earnings report is expected by WallStreet, according to RTT. Analysts have anticipation on stock’s EPS of $0.54. That’s up 92.86 % from last year’s $0.28 EPS. If $0.54 is reported, OMCL’s profit will hit $21.40M for 32.85 P/E. After $0.49 EPS was revealed previous quarter, analysts now see EPS growth of 10.20 % for Omnicell, Inc..

King Luther Management Corporation has invested 0.03% in Omnicell, Inc. (NASDAQ:OMCL). Moreover, Segall Bryant And Hamill Ltd Llc has 0.05% invested in Omnicell, Inc. (NASDAQ:OMCL) for 57,888 shs. Dubuque Fincl Bank And Tru has 6,086 shs. Juncture Wealth Strategies Ltd Co has invested 0.66% in Omnicell, Inc. (NASDAQ:OMCL). Northern Trust holds 529,419 shs. Aqr Cap Ltd Llc reported 6,359 shs. Paloma Prtn Mgmt holds 0.01% in Omnicell, Inc. (NASDAQ:OMCL) or 5,989 shs. Advisory Service Ntwk Ltd Liability Co accumulated 23 shs. Swiss State Bank holds 68,600 shs or 0% of its capital. Zurcher Kantonalbank (Zurich Cantonalbank) holds 1,812 shs. Ontario – Canada-based Bancorporation Of Montreal Can has invested 0% in Omnicell, Inc. (NASDAQ:OMCL). Pier Cap Ltd Limited Liability Company owns 150,926 shs. Louisiana State Employees Retirement Systems holds 17,400 shs. Fisher Asset Ltd Liability Corporation accumulated 0.03% or 432,918 shs. Old Natl Bankshares In accumulated 6,985 shs or 0.02% of the stock.

Omnicell, Inc. had 15 sales and 0 insider purchases since June 5, 2018. This’s net activity of $7.47 million. $453,278 worth of Omnicell, Inc. (NASDAQ:OMCL) shs were sold by Kuipers Peter J.. On Tuesday, June 19 $1.44M worth of Omnicell, Inc. (NASDAQ:OMCL) was sold by LIPPS RANDALL A. On Wednesday, August 1 $1.04 million worth of Omnicell, Inc. (NASDAQ:OMCL) was sold by Taborga Jorge R.. On Tuesday, June 19 Ngo Nhat H also sold $213,946 worth of Omnicell, Inc. (NASDAQ:OMCL). $293,812 worth of stock was sold by Judson James T on Wednesday, August 1. On Tuesday, June 5 DREW J CHRISTOPHER sold $471,778 worth of Omnicell, Inc. (NASDAQ:OMCL) or 9,401 shs.

Omnicell, Inc. (NASDAQ:OMCL) Ratings Coverage

In total 6 analysts cover Omnicell (NASDAQ:OMCL). “Buy” rating has 4, “Sell” are 0, while 2 are “Hold”. 67% are bullish. 6 are the (NASDAQ:OMCL)’s analyst reports since June 29, 2018 according to StockzIntelligence Inc. On Friday, July 27 the stock of Omnicell, Inc. (NASDAQ:OMCL) earned “Buy” rating by Craig Hallum. On Friday, October 26 the stock of Omnicell, Inc. (NASDAQ:OMCL) earned “Overweight” rating by Cantor Fitzgerald. On Friday, July 27 PiperJaffray maintained the shares of OMCL in report with “Neutral” rating. On Friday, June 29 the rating was reinitiated by Benchmark with “Buy”. On Monday, October 29 the stock of Omnicell, Inc. (NASDAQ:OMCL) has “Market Perform” rating given by Wells Fargo. On Friday, October 26 the firm earned “Outperform” rating by Oppenheimer.

For more Omnicell, Inc. (NASDAQ:OMCL) news posted recently go to: Nasdaq.com, Nasdaq.com, Prnewswire.com, Seekingalpha.com or Nasdaq.com. The titles are as follows: “Noteworthy Tuesday Option Activity: OMCL, HOME, AZO – Nasdaq” posted on October 23, 2018, “Omnicell (OMCL) Earnings & Revenues Beat Estimates in Q3 – Nasdaq” on October 26, 2018, “Omnicell Launches Vision for Fully Digitized, Autonomous Pharmacy at Annual ASHP Midyear Meeting – PRNewswire” with a publish date: December 03, 2018, “Omnicell, Inc. (OMCL) CEO Randall Lipps on Q3 2018 Results – Earnings Call Transcript – Seeking Alpha” and the last “Notable Monday Option Activity: HELE, OMCL, CAT – Nasdaq” with publication date: October 08, 2018.

Omnicell, Inc. (NASDAQ:OMCL) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.